Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge
ABSTRACT New vaccine technologies are being investigated for their ability to elicit broadly cross-protective immunity against a range of influenza viruses. We compared the efficacies of two intranasally delivered nonreplicating influenza virus vaccines (H1 and H5 S-FLU) that are based on the suppre...
Guardado en:
Autores principales: | Mariana Baz, Kobporn Boonnak, Myeisha Paskel, Celia Santos, Timothy Powell, Alain Townsend, Kanta Subbarao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/79a9b26e4bc64166a35f0eb2fe4f499e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.
por: Penghui Yang, et al.
Publicado: (2012) -
Epitope-targeting platform for broadly protective influenza vaccines.
por: David F Zeigler, et al.
Publicado: (2021) -
Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins
por: Linda S. Wyatt, et al.
Publicado: (2017) -
Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
por: Daniel Stadlbauer, et al.
Publicado: (2017) -
Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.
por: Byoung-Shik Shim, et al.
Publicado: (2011)